RAFAEL
BAÑARES CAÑIZARES
Catedrático de universidad
Vall d'Hebron Institut de Recerca
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Vall d'Hebron Institut de Recerca (24)
2023
-
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode
Liver International, Vol. 43, Núm. 7, pp. 1548-1557
-
Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
Gut, Vol. 72, Núm. 4, pp. 749-758
-
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome
Transplantation, Vol. 107, Núm. 6, pp. 1330-1340
-
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Hepatology (Baltimore, Md.), Vol. 77, Núm. 6, pp. 2052-2062
-
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Cell death & disease, Vol. 14, Núm. 8, pp. 514
2022
-
HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
Journal of Hepatology, Vol. 76, Núm. 4, pp. 812-821
2021
-
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Journal of Hepatology, Vol. 75, Núm. 3, pp. 589-599
-
Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis
Journal of Hepatology, Vol. 75, Núm. 2, pp. 342-350
-
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10
-
Fat: Quality, or quantity? what matters most for the progression of metabolic associated fatty liver disease (mafld)
Biomedicines, Vol. 9, Núm. 10
-
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
JHEP Reports, Vol. 3, Núm. 6
2020
-
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Journal of Hepatology, Vol. 72, Núm. 4, pp. 688-701
-
Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701] (Journal of Hepatology (2020) 72(4) (688–701), (S0168827819306968), (10.1016/j.jhep.2019.11.009))
Journal of Hepatology
-
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-Analysis
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 313-327.e6
-
Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort
Journal of Hepatology, Vol. 72, Núm. 4, pp. 702-710
-
Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS
Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091
2019
-
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH
Gastroenterologia y Hepatologia, Vol. 42, Núm. 10, pp. 657-676
-
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
The Lancet, Vol. 393, Núm. 10181, pp. 1597-1608
2018
-
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis
Gastroenterology, Vol. 154, Núm. 6, pp. 1694-1705.e4
-
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Gastroenterologia y Hepatologia, Vol. 41, Núm. 5, pp. 328-349